These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29187487)

  • 21. Stereotactic body radiotherapy (SBRT) in recurrent or oligometastatic pancreatic cancer : A toxicity review of simultaneous integrated protection (SIP) versus conventional SBRT.
    Gkika E; Adebahr S; Kirste S; Schimek-Jasch T; Wiehle R; Claus R; Wittel U; Nestle U; Baltas D; Grosu AL; Brunner TB
    Strahlenther Onkol; 2017 Jun; 193(6):433-443. PubMed ID: 28138949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region.
    Siddiqui F; Patel M; Khan M; McLean S; Dragovic J; Jin JY; Movsas B; Ryu S
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1047-53. PubMed ID: 19327895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Robotic Stereotactic Body Radiation Therapy in Patients With Recurrent or Metastatic Abdominopelvic Tumors: A Single Institute Experience.
    Sezen D; Gurkaynak M; Gultekin M; Cengiz M; Yildiz F; Zorlu F; Akyol F; Yazici G; Hurmuz P; Ozyigit G
    Technol Cancer Res Treat; 2016 Feb; 15(1):203-11. PubMed ID: 25687510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.
    Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM
    Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereotactic body radiation therapy in recurrent hepatocellular carcinoma.
    Huang WY; Jen YM; Lee MS; Chang LP; Chen CM; Ko KH; Lin KT; Lin JC; Chao HL; Lin CS; Su YF; Fan CY; Chang YW
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):355-61. PubMed ID: 22342300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereotactic body radiotherapy (SBRT) in the management of extracranial oligometastatic (OM) disease.
    Bhattacharya IS; Woolf DK; Hughes RJ; Shah N; Harrison M; Ostler PJ; Hoskin PJ
    Br J Radiol; 2015 Apr; 88(1048):20140712. PubMed ID: 25679321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes and toxicity for hypofractionated and single-fraction image-guided stereotactic radiosurgery for sarcomas metastasizing to the spine.
    Folkert MR; Bilsky MH; Tom AK; Oh JH; Alektiar KM; Laufer I; Tap WD; Yamada Y
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1085-91. PubMed ID: 24661662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of stereotactic body radiation therapy to cancer liver metastasis.
    Zhang SY; Zhu GY; Li G; Zhang YB; Geng JH
    Cancer Lett; 2016 Sep; 379(2):225-9. PubMed ID: 26704306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients.
    Sanuki N; Takeda A; Oku Y; Mizuno T; Aoki Y; Eriguchi T; Iwabuchi S; Kunieda E
    Acta Oncol; 2014 Mar; 53(3):399-404. PubMed ID: 23962244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic liver function after stereotactic body radiation therapy for hepatocellular carcinoma.
    Dreher C; Høyer KI; Fode MM; Habermehl D; Combs SE; Høyer M
    Acta Oncol; 2016 Jul; 55(7):886-91. PubMed ID: 26878669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity.
    Pollom EL; Alagappan M; von Eyben R; Kunz PL; Fisher GA; Ford JA; Poultsides GA; Visser BC; Norton JA; Kamaya A; Cox VL; Columbo LA; Koong AC; Chang DT
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):918-25. PubMed ID: 25585785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local Control After Stereotactic Body Radiation Therapy for Liver Tumors.
    Ohri N; Tomé WA; Méndez Romero A; Miften M; Ten Haken RK; Dawson LA; Grimm J; Yorke E; Jackson A
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):188-195. PubMed ID: 29395629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical results of mean GTV dose optimized robotic guided SBRT for liver metastases.
    Andratschke N; Parys A; Stadtfeld S; Wurster S; Huttenlocher S; Imhoff D; Yildirim M; Rades D; Rödel CM; Dunst J; Hildebrandt G; Blanck O
    Radiat Oncol; 2016 May; 11():74. PubMed ID: 27236333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypofractionated stereotactic body radiotherapy for primary and metastatic liver tumors using the novalis image-guided system: preliminary results regarding efficacy and toxicity.
    Iwata H; Shibamoto Y; Hashizume C; Mori Y; Kobayashi T; Hayashi N; Kosaki K; Ishikawa T; Kuzuya T; Utsunomiya S
    Technol Cancer Res Treat; 2010 Dec; 9(6):619-27. PubMed ID: 21070084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gallbladder toxicity and high-dose ablative-intent radiation for liver tumors: Should we constrain the dose?
    Tanguturi SK; Niemierko A; Wo JY; Nguyen KN; Prichard H; Zhu AX; Wolfgang JA; Hong TS
    Pract Radiat Oncol; 2017; 7(5):e323-e329. PubMed ID: 28341320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Stereotactic body radiation therapy for hepatocellular carcinoma: Results from a retrospective multicentre study].
    Scher N; Janoray G; Riet FG; Le Bayon AG; Debbi K; Lévy S; Louisot P; Garaud P; Chajon E; Barillot I; Salamé É; de Crevoisier R; Chapet S; Calais G
    Cancer Radiother; 2019 Apr; 23(2):104-115. PubMed ID: 30952560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stereotactic body radiotherapy for primary hepatic malignancies - Report of a phase I/II institutional study.
    Weiner AA; Olsen J; Ma D; Dyk P; DeWees T; Myerson RJ; Parikh P
    Radiother Oncol; 2016 Oct; 121(1):79-85. PubMed ID: 27566894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereotactic body radiotherapy for primary hepatocellular carcinoma.
    Andolino DL; Johnson CS; Maluccio M; Kwo P; Tector AJ; Zook J; Johnstone PA; Cardenes HR
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e447-53. PubMed ID: 21645977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereotactic body radiation therapy for liver metastasis from colorectal cancer: size matters.
    Flamarique S; Campo M; Asín G; Pellejero S; Viúdez A; Arias F
    Clin Transl Oncol; 2020 Dec; 22(12):2350-2356. PubMed ID: 32488803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.
    Su TS; Lu HZ; Cheng T; Zhou Y; Huang Y; Gao YC; Tang MY; Jiang HY; Lian ZP; Hou EC; Liang P
    BMC Cancer; 2016 Nov; 16(1):834. PubMed ID: 27809890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.